Friday, November 6, 2020
- 9:00AM-11:00AM
-
Abstract Number: 0009
Prevalence of Hydroxychloroquine and Chloroquine Side Effects in Rheumatology Patients: A Retrospective Survey of 115 Cases
Epidemiology & Public Health Poster I: COVID-19 & Rheumatic Disease- 9:00AM-11:00AM
-
Abstract Number: 0185
Prevalence of Migraine and Neuropathic Pain in Rheumatic Disease
RA – Diagnosis, Manifestations, & Outcomes Poster I: Multimorbidity- 9:00AM-11:00AM
-
Abstract Number: 0132
Prevalence of Osteoporosis and Fragitlity Fractures Is Not Different Between ACPA Positive Patients Compared to ACPA Negative Patients in a Real World Setting, Despite Longer Disease Duration and Glucocorticoid-Treatment
Osteoporosis & Metabolic Bone Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 0081
Prevalence of Systemic Autoimmune Diseases in Polycystic Ovary Syndrome
Miscellaneous Rheumatic & Inflammatory Diseases Poster I: Diagnosis and Testing- 9:00AM-11:00AM
-
Abstract Number: 0418
Prevalence of Thyroid Disease Among Patients with Vasculitis
Vasculitis – Non-ANCA-Associated & Related Disorders Poster I- 9:00AM-11:00AM
-
Abstract Number: 0021
Prioritizing Patient Safety While Maintaining Study Integrity During COVID-19: Lupus Intervention Fatigue Trial Modifications and Lessons Learned
Epidemiology & Public Health Poster I: COVID-19 & Rheumatic Disease- 9:00AM-11:00AM
-
Abstract Number: 0018
PROMIS-29 and Health Related Quality of Life in Rheumatology Outpatients During the COVID-19 Pandemic in New York City
Epidemiology & Public Health Poster I: COVID-19 & Rheumatic Disease- 9:00AM-11:00AM
-
Abstract Number: 0137
PROMIS-29 Scores Are Significantly Higher in Patients with Rheumatoid Arthritis Who Meet Criteria for Co-morbid Fibromyalgia (FM) Than in Those with Rheumatoid Arthritis and No FM
Patient Outcomes, Preferences, & Attitudes Poster I: RA, Spondyloarthritis, & OA- 9:00AM-11:00AM
-
Abstract Number: 0420
Prospective Analysis of the Prevalence of Giant Cell Arteritis in Consecutive Newly Diagnosed Patients with Polymyalgia Rheumatica
Vasculitis – Non-ANCA-Associated & Related Disorders Poster I- 9:00AM-11:00AM
-
Abstract Number: 0038
Protein Biomarkers May Differentiate Responders and Non-Responders to Adalimumab, a Tumour Necrosis Factor Inhibitor, in Ankylosing Spondylitis Patients – The Bioefficacy SpA Study
Genetics, Genomics & Proteomics Poster- 9:00AM-11:00AM
-
Abstract Number: 0279
Pulmonary Involvement in a Single Center Cohort of Patients with Systemic Lupus Erythematosus
SLE – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Manifestations- 9:00AM-11:00AM
-
Abstract Number: 0006
Race/ethnicity Is Associated with Poor Health Outcomes Amongst Rheumatic Disease Patients Diagnosed with COVID-19 in the US: Data from the COVID-19 Global Rheumatology Alliance Physician-Reported Registry
Epidemiology & Public Health Poster I: COVID-19 & Rheumatic Disease- 9:00AM-11:00AM
-
Abstract Number: 0042
Racial and Ethnic Differences in a Multiple Biochemical Measure of Rheumatoid Arthritis Disease Activity
Healthcare Disparities in Rheumatology Poster- 9:00AM-11:00AM
-
Abstract Number: 0055
Racial and Sex-based Disparities in Health Care Utilization: Eye Inflammation as a Paradigm